Wei-ting Wang
Nanjing, 210029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
PTPN2 Inhibition Disrupts Mitochondrial Renewal and Blocks TFRC-Mediated Mitophagy to Exert Anti-Tumor Activities in ALK-Positive Anaplastic Large Cell Lymphoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 04, 2024
SH3GL1-activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B-cell lymphoma.
Journal: Clinical and translational medicine
Published: October 21, 2024
CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
Journal: Cancer letters
Published: September 08, 2023
MYC-induced cytidine metabolism regulates survival and drug resistance via cGas-STING pathway in mantle cell lymphoma.
Journal: British journal of haematology
Published: February 25, 2023
Dynamic changes in circulating EBV-DNA load during treatment have prognostic values in EBV+ DLBCL-NOS: a Chinese cohort study.
Journal: Annals of hematology
Published: October 28, 2022
Establishment and comprehensive analysis of a new human cell line (NK-NJ) with NK-cell characteristics established from extranodal natural killer cell lymphoma/leukemia.
Journal: Human cell
Published: August 18, 2022
Low T3 syndrome as a predictor of poor outcomes in patients with follicular lymphoma.
Journal: Annals of hematology
Published: July 10, 2022
The prognostic value of 25-hydroxy vitamin D deficiency and its interaction with c-Myc expression in diffuse large B cell lymphoma.
Journal: Annals of hematology
Published: April 16, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026